Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension
Completed · Phase 3
Conditions studied: Pulmonary Hypertension
In brief
The primary objective of this study was to evaluate the safety and efficacy of ambrisentan in a broad population of participants with pulmonary hypertension (PH). Secondary objectives of this study were to evaluate the effects of ambrisentan on other clinical measures of pulmonary arterial hypertension (PAH), long-term treatment success, and survival.
Key facts
- Study ID
- NCT00380068
- Run by
- Gilead Sciences
- People needed
- 224
- Starts
- 2006-08-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2012-04-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- Arizona Pulmonary Specialists, Ltd — Phoenix, Arizona, United States
- UCSD Medical Center, Thornton Hospital — La Jolla, California, United States
- Greater Los Angeles, VA Medical Center — Los Angeles, California, United States
- Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center — Torrance, California, United States
- University of Colorado Health Sciences Center — Aurora, Colorado, United States
- University of Connecticut Health Center — Farmington, Connecticut, United States
- Pulmonary Hypertension Clinic Mount Sinai Medical Center — Miami Beach, Florida, United States
- Suncoast Lung Center — Sarasota, Florida, United States
- Medical College of Georgia — Augusta, Georgia, United States
- Atlanta Institute for Medical Research, Inc. — Decatur, Georgia, United States
- University of Chicago Hospitals — Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- Tufts-New England Medical Center — Boston, Massachusetts, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Boston Adult Congenital Heart Service — Boston, Massachusetts, United States
- Boston University School of Medicine — Boston, Massachusetts, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- University of Medicine & Dentistry of New Jersey — Newark, New Jersey, United States
- Newark Beth Israel Medical Center — Newark, New Jersey, United States
- New York Presbyterian Pulmonary Hypertension Center — New York, New York, United States
- Mary Parkes Asthma Center — Rochester, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.